Phytonadione Injectable Emulsion recalled for failed stability testing
Dr. Reddy's Laboratories is recalling Phytonadione Injectable Emulsion USP due to out-of-specification aluminum content results found during 12-month stability testing.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall, which by definition is unlikely to cause adverse health consequences. The hazard is a manufacturing/stability issue with no reported illnesses or injuries, making it a low-risk, precautionary recall.
Plain-English summary
Dr. Reddy's Laboratories, Inc. is recalling Phytonadione Injectable Emulsion USP, 10 mg/mL, distributed nationwide. The recall was initiated because stability testing at 12 months revealed aluminum content results that were out of specification.
Phytonadione is a prescription injectable medication containing Vitamin K, used to reverse anticoagulation and increase prothrombin activity. It is administered by intramuscular, intravenous, or subcutaneous injection.
The affected lot is ACB101 with expiration date 03/2023, consisting of 2,838 ampules (25 single-dose ampules per carton, NDC 43598-405-16).
Patients using this medication should contact their healthcare provider or pharmacist. Do not stop taking or using this medication without speaking to a healthcare professional, as abrupt discontinuation could have serious consequences.
The recalled product
- Product
- PHYTONADIONE (PHYTONADIONE)
- Brand
- PHYTONADIONE
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Category
- Drug — Injectable / Vitamin K
- Affected units
- 2,838
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # ACB101
- Exp 03/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · PHYTONADIONE
- ModeratePhytonadione injectable emulsion vials recalled after failing stability testing specifications
FDA (Drugs) · 2025-12-10
- SevereDr. Reddy's Recalls Phytonadione Ampules Due to Breaking and Shattering
FDA (Drugs) · 2020-04-08
Same manufacturer · Dr. Reddy's Laboratories, Inc.
See all →- ModerateVarenicline tablets recalled after an assay value fell below specification
FDA (Drugs) · 2025-12-17
- Moderate
- HighOmeprazole capsule bottle contained a foreign divalproex sodium tablet
FDA (Drugs) · 2025-07-23
- SevereLevetiracetam Injection Label Mismatch Nationwide Recall
FDA (Drugs) · 2025-04-23
- ModerateFDA Recalls JAVYGTOR Tablets Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2024-12-18
Same hazard · failed stability testing
See all →- ModeratePain Aid ESF Bulk Tablets Recall Due to Manufacturing Process Failures
FDA (Drugs) · 2022-01-12
- ModerateXpect First Aid Extra Strength Pain Away tablets recalled for failed stability specifications
FDA (Drugs) · 2021-11-03